AU2009255777A1 - Concentration assay - Google Patents

Concentration assay Download PDF

Info

Publication number
AU2009255777A1
AU2009255777A1 AU2009255777A AU2009255777A AU2009255777A1 AU 2009255777 A1 AU2009255777 A1 AU 2009255777A1 AU 2009255777 A AU2009255777 A AU 2009255777A AU 2009255777 A AU2009255777 A AU 2009255777A AU 2009255777 A1 AU2009255777 A1 AU 2009255777A1
Authority
AU
Australia
Prior art keywords
cycle
calibration
analyte
sample
virtual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009255777A
Other languages
English (en)
Inventor
Peter Borg
Asa Frostell-Karlsson
Markku Hamalainen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences Corp
Publication of AU2009255777A1 publication Critical patent/AU2009255777A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/65—Raman scattering
    • G01N21/658—Raman scattering enhancement Raman, e.g. surface plasmons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/55—Specular reflectivity
    • G01N21/552—Attenuated total reflection
    • G01N21/553—Attenuated total reflection and using surface plasmons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/10—Competitive assay format

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
AU2009255777A 2008-06-02 2009-06-01 Concentration assay Abandoned AU2009255777A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0801304 2008-06-02
SE0801304-7 2008-06-02
SE0950272-5 2009-04-24
SE0950272 2009-04-24
PCT/SE2009/050638 WO2009148396A1 (en) 2008-06-02 2009-06-01 Concentration assay

Publications (1)

Publication Number Publication Date
AU2009255777A1 true AU2009255777A1 (en) 2009-12-10

Family

ID=41398332

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2009255777A Abandoned AU2009255777A1 (en) 2008-06-02 2009-06-01 Concentration assay
AU2009255776A Abandoned AU2009255776A1 (en) 2008-06-02 2009-06-01 Method for virus detection

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2009255776A Abandoned AU2009255776A1 (en) 2008-06-02 2009-06-01 Method for virus detection

Country Status (6)

Country Link
US (3) US10823677B2 (cg-RX-API-DMAC7.html)
EP (2) EP2294226A4 (cg-RX-API-DMAC7.html)
JP (2) JP5730192B2 (cg-RX-API-DMAC7.html)
CN (2) CN102046815A (cg-RX-API-DMAC7.html)
AU (2) AU2009255777A1 (cg-RX-API-DMAC7.html)
WO (2) WO2009148395A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009255777A1 (en) * 2008-06-02 2009-12-10 Ge Healthcare Bio-Sciences Ab Concentration assay
WO2012174014A2 (en) 2011-06-13 2012-12-20 Indevr, Inc. Low density microarrays for vaccine related protein quantification, potency determination and efficacy evaluation
EP2657681A1 (en) * 2012-04-26 2013-10-30 Roche Diagnostics GmbH Improvement of the sensitivity and the dynamic range of photometric assays by generating multiple calibration curves
US20150093839A1 (en) * 2013-10-02 2015-04-02 General Electric Company Methods and systems for detection of target and applications thereof
US20160313316A1 (en) * 2013-12-10 2016-10-27 Agency For Science, Technology And Research Surface acoustic wave sensor for influenza detection
SG11201606798QA (en) 2014-02-28 2016-09-29 Nitto Denko Corp Urinalysis device and dry reagent for quantitative urinalysis
US10732180B2 (en) 2014-06-04 2020-08-04 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
US10161850B2 (en) 2015-03-23 2018-12-25 Intellicyt Corporation Evaluating biological material for unassociated virus-size particles with influenza virus epitope
GB201511587D0 (en) * 2015-07-02 2015-08-19 Ge Healthcare Bio Sciences Ab A method and a system for determining a concentration range for a sample by means of a calibration curve
US20170212050A1 (en) * 2016-01-22 2017-07-27 Ionfield Holdings, Llc Method for calibrating and using calibration of microplates
EP3296741B1 (en) * 2016-09-14 2019-08-21 Serum Institute of India Private Limited Multiplex bead based assay for quantification of multiple types of carrier protein in a multivalent conjugate vaccine composition
CN110044997B (zh) * 2018-01-15 2023-08-04 中国医学科学院药物研究所 一种体内药物的离子强度虚拟校正和定量质谱成像分析方法
GB2578163A (en) * 2018-10-19 2020-04-22 Univ Pretoria Plant produced avian influenza antigens and their uses in diagnostic assays and devices
JP7233880B2 (ja) * 2018-10-22 2023-03-07 キヤノンメディカルシステムズ株式会社 ウイルスｒｎａ単離方法及びウイルス定量方法
CN111487405A (zh) * 2020-04-03 2020-08-04 山东泰邦生物制品有限公司 一种快速高通量定量检测病毒特异性抗体的方法
CN112255212B (zh) * 2020-10-15 2022-08-05 天津大学 检测h5n1甲型流感病毒血凝素的方法
CN112557647B (zh) * 2020-12-10 2024-07-05 宁波华仪宁创智能科技有限公司 基于免疫层析技术的检测方法及应用
KR20230130683A (ko) * 2021-01-11 2023-09-12 메소 스케일 테크놀러지즈, 엘엘시 검정 시스템 교정 시스템 및 방법
CN112964870B (zh) * 2021-02-03 2024-01-26 军事科学院军事医学研究院军事兽医研究所 一种基于spr生物传感器的流感病毒快速检测方法
US12669424B2 (en) * 2022-11-04 2026-06-30 American Ecotech L.C. Mass concentration determination of particles smaller than 2.5 microns in air
DE102022134580A1 (de) * 2022-12-22 2024-06-27 Endress+Hauser Conducta Gmbh+Co. Kg Verfahren zum Kalibrieren eines Sensors im laufenden Betrieb, Sensor mit implementiertem Verfahren zur Kalibration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85137A (en) 1987-01-21 1992-02-16 Ares Serono Res & Dev Ltd Method of assaying for a ligand using surface plasmon resonance effect
SE462408B (sv) * 1988-11-10 1990-06-18 Pharmacia Ab Optiskt biosensorsystem utnyttjande ytplasmonresonans foer detektering av en specific biomolekyl, saett att kalibrera sensoranordningen samt saett att korrigera foer baslinjedrift i systemet
SE8804074D0 (sv) * 1988-11-10 1988-11-10 Pharmacia Ab Sensorenhet och dess anvaendning i biosensorsystem
SE462454B (sv) * 1988-11-10 1990-06-25 Pharmacia Ab Maetyta foer anvaendning i biosensorer
JPH0354467A (ja) 1989-07-24 1991-03-08 Asahi Chem Ind Co Ltd ウイルス濃度の測定方法および測定装置
GB9518429D0 (en) * 1995-09-08 1995-11-08 Pharmacia Biosensor A rapid method for providing kinetic and structural data in molecular interaction analysis
JP3645023B2 (ja) * 1996-01-09 2005-05-11 富士写真フイルム株式会社 試料分析方法、検量線の作成方法及びそれを用いる分析装置
SE9604575D0 (sv) 1996-12-12 1996-12-12 Biacore Ab Method and system for analyte determination
US6111652A (en) * 1998-07-14 2000-08-29 Texas Instruments Incorporated High throughput surface plasmon resonance analysis system
PL355287A1 (en) * 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
JP3515101B2 (ja) * 2000-06-27 2004-04-05 中外製薬株式会社 リガンドとリガンド結合蛋白質との結合活性を評価する方法
US6477392B1 (en) * 2000-07-14 2002-11-05 Futrex Inc. Calibration of near infrared quantitative measurement device using optical measurement cross-products
EP1766398B1 (en) 2004-06-24 2011-01-05 GE Healthcare Bio-Sciences AB Method for detecting molecular surface interactions
WO2006041392A1 (en) * 2004-10-13 2006-04-20 Biacore Ab Preparation and use of a reactive solid support surface
SE0402476D0 (sv) * 2004-10-13 2004-10-13 Biacore Ab Preparation and use of a reactive solid support surface
FR2921928B1 (fr) * 2007-10-08 2011-03-04 Sanofi Pasteur Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal
AU2009255777A1 (en) * 2008-06-02 2009-12-10 Ge Healthcare Bio-Sciences Ab Concentration assay

Also Published As

Publication number Publication date
JP2011522250A (ja) 2011-07-28
CN102046814B (zh) 2015-05-20
EP2294227A1 (en) 2011-03-16
US20110076703A1 (en) 2011-03-31
WO2009148395A1 (en) 2009-12-10
EP2294227B1 (en) 2015-08-12
AU2009255776A1 (en) 2009-12-10
US20210215613A1 (en) 2021-07-15
CN102046815A (zh) 2011-05-04
EP2294226A1 (en) 2011-03-16
CN102046814A (zh) 2011-05-04
US10823677B2 (en) 2020-11-03
EP2294227A4 (en) 2011-10-12
JP5730192B2 (ja) 2015-06-03
WO2009148396A1 (en) 2009-12-10
US20110070574A1 (en) 2011-03-24
EP2294226A4 (en) 2011-09-28
JP2011522249A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
US20210215613A1 (en) Concentration assay
Jönsson et al. Real-time biospecific interaction analysis
Beusink et al. Angle-scanning SPR imaging for detection of biomolecular interactions on microarrays
US11796536B2 (en) Method for determining analyte-ligand binding on a sensor surface
EP1766398B1 (en) Method for detecting molecular surface interactions
EP3213071B1 (en) Method to determine solvent correction curves
US20110152120A1 (en) method of characterizing antibodies
JP4751387B2 (ja) 分子表面相互作用を検出する方法
WO2026068442A1 (en) Concentration assessment
Cho et al. Minimum-step immuno-analysis based on continuous recycling of the capture antibody
CN1811384A (zh) 基于固相表面增强光散射的生物分子相互作用分析方法

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period